ATHENEX
Athenex focuses on the development and commercialization of therapies for cancer and immunomodulatory diseases. Its mission is to become a global leader in bringing innovative cancer treatments to the market and improve health outcomes. The company was founded in 2003 in Buffalo, New York, and has since grown to have operations across the U.S., China, Hong Kong, Taiwan, and the U.K.
ATHENEX
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2003-01-01
Address:
Buffalo, New York, United States
Country:
United States
Website Url:
http://www.athenex.com
Total Employee:
251+
Status:
Active
Contact:
716-427-2950
Email Addresses:
[email protected]
Total Funding:
342.15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Agenus
Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals specializes in the development and commercialization of ophthalmic products for the treatment of eye diseases.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Synta Pharmaceuticals
Synta Pharmaceuticals is focused on developing and commercializing small molecule drugs to treat cancer and chronic inflammatory diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-05-04 | Kuur Therapeutics | Kuur Therapeutics acquired by Athenex | 185 M USD |
| 2015-12-14 | Comprehensive Drug Enterprises Ltd | Comprehensive Drug Enterprises Ltd acquired by Athenex | N/A |
| 2014-09-09 | QuaDPharma | QuaDPharma acquired by Athenex | N/A |
Investors List
Kingdon Capital
Kingdon Capital investment in Post-IPO Equity - Athenex
OrbiMed
OrbiMed investment in Post-IPO Equity - Athenex
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Athenex
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Athenex
Mandra Capital
Mandra Capital investment in Private Equity Round - Athenex
Mandra Capital
Mandra Capital investment in Private Equity Round - Athenex
Mandra Capital
Mandra Capital investment in Venture Round - Athenex
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-08 | Athenex Appoints Darrel P. Cohen, MD, PhD as Chief Medical Officer of Cell Therapy |
| 2022-02-22 | Athenex Announces Appointment of Chief Financial Officer |
Official Site Inspections
http://www.athenex.com Semrush global rank: 2.16 M Semrush visits lastest month: 9.21 K
Unable to get host informations!!!
